These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1380558)

  • 21. New trends in prenatal screening for chromosomal abnormalities.
    Addar MH
    Saudi Med J; 2000 May; 21(5):429-32. PubMed ID: 11500675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MULTISCAN--a Scandinavian multicenter second trimester obstetric ultrasound and serum screening study.
    Jørgensen FS; Valentin L; Salvesen KA; Jørgensen C; Jensen FR; Bang J; Eik-Nes SH; Madsen M; Marsal K; Persson PH; Philip J; Bogstad JW; Nørgaard-Pedersen B
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):501-10. PubMed ID: 10376859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomaly.
    Celentano C; Guanciali-Franchi PE; Liberati M; Palka C; Fantasia D; Morizio E; Calabrese G; Stuppia L; Rotmensch S
    Prenat Diagn; 2005 Mar; 25(3):220-4. PubMed ID: 15791663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal diagnosis. Amniocentesis.
    McNay MB; Whitfield CR
    Br J Hosp Med; 1984 Jun; 31(6):406-7, 410-11, 13 passim. PubMed ID: 6204708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal serum triple analyte screening in pregnancy.
    Graves JC; Miller KE; Sellers AD
    Am Fam Physician; 2002 Mar; 65(5):915-20. PubMed ID: 11898965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
    Macri JN; Kasturi RV; Krantz DA; Cook EJ
    Obstet Gynecol; 1991 Jun; 77(6):963-5. PubMed ID: 1709482
    [No Abstract]   [Full Text] [Related]  

  • 28. [Maternal serum screening for Down syndrome and neural tube defects].
    van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH
    Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Trisomy 21 screening: value of ultrasound and serum markers in a combined approach].
    Senat MV; Rozenberg P; Bernard JP; Ville Y
    J Gynecol Obstet Biol Reprod (Paris); 2001 Feb; 30(1):11-27. PubMed ID: 11240502
    [No Abstract]   [Full Text] [Related]  

  • 30. Screening for fetal chromosomal abnormalities by maternal serum biochemistry and ultrasound examination of fetal morphology.
    Hecher K; Snijders R; Nicolaides K
    Curr Opin Obstet Gynecol; 1993 Apr; 5(2):170-8. PubMed ID: 7683916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prenatal diagnosis. I: Prenatal diagnosis program at the Medical Genetics Unit of the Universidad de Zulia, Maracaibo, Venezuela].
    Prieto-Carrasquero M; Molero A; Carrasquero N; Paz V; González S; Pineda-Del Villar L; Del Villar A; Rojas-Atencio A; Quintero M; Fulcado W; Mena R; Morales-Machin A
    Invest Clin; 1998 Jun; 39(2):97-116. PubMed ID: 9707921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Triple screening for trisomy 21: prospective results of 7039 assessments].
    Pescia G; Dao MH; Weihs D; Gaide AC; Loertscher A; Hohlfeld P; Marguerat P; Nguyen The H; Paccaud F; Maillard C
    Rev Med Suisse Romande; 1993 Apr; 113(4):277-80. PubMed ID: 7684852
    [No Abstract]   [Full Text] [Related]  

  • 34. [Round table discussion. Amniocentesis before 15 weeks of amenorrhea. Limits of the method].
    Dubost C; Thoulon JM; Germain D; Guibaud S
    Rev Fr Gynecol Obstet; 1991 Nov; 86(11):687-91. PubMed ID: 1723531
    [No Abstract]   [Full Text] [Related]  

  • 35. Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS).
    Craig WY; Haddow JE; Palomaki GE; Roberson M
    Prenat Diagn; 2007 May; 27(5):409-14. PubMed ID: 17286308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for fetal disorders by measuring alpha-fetoprotein levels in maternal serum.
    Haddow JE
    Ala J Med Sci; 1988 Apr; 25(2):168-72. PubMed ID: 2455453
    [No Abstract]   [Full Text] [Related]  

  • 37. [Screening for congenital anomalies in mid-term pregnancy. Prospective epidemiologic study. Fetal trisomy].
    Tóth-Pál E; Oroszné Nagy J; Papp C; Szabó M; Veress L; Török O; Tóth Z; Papp Z
    Orv Hetil; 1995 Feb; 136(9):483-9. PubMed ID: 7535413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasound screening for fetal structural anomalies.
    Gomez KJ; Copel JA
    Curr Opin Obstet Gynecol; 1993 Apr; 5(2):204-10. PubMed ID: 8490090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serum screening of pregnant women reveals Down syndrome. Analysis of biochemical markers for earlier detection].
    Christiansen M; Larsen SO; Nørgaard-Pedersen B
    Lakartidningen; 1997 Dec; 94(51-52):4898-902. PubMed ID: 9454010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comment on the contribution by Benz et al.: Serum screening for Down syndrome in women under 35 years of age with an age independent index].
    Reynolds T; Pistorius K; Spencer K; John R
    Z Geburtshilfe Neonatol; 1995; 199(3):128-9. PubMed ID: 7553259
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.